A randomized phase II (/III) study of TXT/TS-1 (DS) combination vs CDDP/5-FU therapy (FUP) in metastatic gastric cancer.
Phase of Trial: Phase II/III
Latest Information Update: 06 Sep 2013
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Fluorouracil
- Indications Gastric cancer
- Focus Therapeutic Use
- 19 Sep 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 10 Jul 2009 Updated phase II results presented at ASCO 2009.
- 03 Jun 2009 New trial record.